Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Suplatast tosilate by Melius Pharma for Idiopathic Pulmonary Fibrosis: Likelihood of Approval
Suplatast tosilate is under clinical development by Melius Pharma and currently in Phase II for Idiopathic Pulmonary Fibrosis. According to...
Data Insights
Suplatast tosilate by Melius Pharma for Cough: Likelihood of Approval
Suplatast tosilate is under clinical development by Melius Pharma and currently in Phase II for Cough. According to GlobalData, Phase...